Trial Profile
A study to evaluate the levels of TNF-α and its soluble receptors during the course of therapy with etanercept and infliximab in patients with ankylosing spondylitis and rheumatoid arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Dec 2015
Price :
$35
*
At a glance
- Drugs Etanercept (Primary) ; Infliximab (Primary)
- Indications Ankylosing spondylitis; Rheumatoid arthritis
- Focus Pharmacodynamics
- 22 Dec 2015 New trial record